31 studies found for:    " July 02, 2008":" August 01, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" July 02, 2008":" August 01, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Lovastatin: Immunomodulatory Value Evaluation
Condition: HIV Seropositivity
Interventions: Drug: Lovastatin;   Other: placebo
2 Completed
Has Results
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: emtricitabine/tenofovir disoproxil fumarate (FTC/TDF);   Drug: raltegravir (RAL)
3 Completed GSK706769/KALETRA Drug-drug Interaction Study
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK706769 & KALETRA
4 Completed
Has Results
Safety and Efficacy Study of Switching From Epzicom to Truvada
Condition: HIV Infection
Interventions: Drug: emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF);   Drug: abacavir (ABC)/lamivudine (3TC)
5 Completed Cohort Study of HIV-1 Incidence Among Clients of the Thai Red Cross AIDS Research Center, Bangkok, Thailand
Condition: HIV Infections
Intervention:
6 Enrolling by invitation Cerebrospinal Fluid (CSF) Raltegravir Substudy
Condition: HIV Infections
Intervention:
7 Completed
Has Results
Single DermaVir Immunization in HIV-1 Infected Patients on HAART
Condition: HIV Infection
Interventions: Biological: DermaVir;   Drug: HAART
8 Active, not recruiting Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients
Condition: HIV Infection
Interventions: Biological: DermaVir;   Biological: Placebo
9 Completed Healthy Activities for Prize Incentives
Conditions: Substance Abuse;   HIV Infections
Intervention: Behavioral: contingency management
10 Active, not recruiting Intervention for (Those) Recently Informed of Seropositive Status (IRISS)
Condition: HIV Infections
Interventions: Behavioral: Skills-Building Intervention;   Behavioral: Personal Interview Group
11 Completed
Has Results
Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)
Conditions: Chronic Hepatitis C;   Hepatitis C;   HIV Infections
Interventions: Biological: PEG-IFN alfa-2b;   Drug: RBV
12 Completed Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy
Condition: HIV Infections
Intervention: Drug: Addition of raltegravir 800 mg QD to HAART
13 Completed Family Centered Advanced Care Planning for Adolescents With HIV/AIDS and Their Families
Condition: HIV Infections
Interventions: Behavioral: Family Centered Advanced Care Planning (FCACP) sessions;   Behavioral: Health education control sessions
14 Unknown  Establishing Normal Values for Neuropsychological Testing in HIV-negative Thais
Condition: HIV Infections
Intervention:
15 Completed The Effect of Vitamin D and Calcium on Bone in Pediatric HIV
Conditions: HIV Infection;   Bone Mass
Intervention: Dietary Supplement: cholecalciferol plus calcium carbonate
16 Completed Impact of an HPV Vaccine in HIV-Infected Young Women
Condition: HIV Infection
Intervention: Biological: HPV vaccine for strains -6, -11, -16, and -18
17 Withdrawn Maraviroc Compassionate Use
Condition: Human Immunodeficiency Virus Type 1
Intervention: Drug: Maraviroc
18 Completed
Has Results
A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
Condition: Human Immunodeficiency Virus Infections
Interventions: Drug: Efavirenz 600mg;   Drug: Boosted Lexiva
19 Completed
Has Results
Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function
Condition: Human Immunodeficiency Virus (HIV) Infection
Interventions: Drug: Maraviroc;   Drug: Ritonavir;   Drug: Saquinavir
20 Completed GSK706769 Repeat Dose Study
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK706769

Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results
Indicates status has not been verified in more than two years